Clinical Summary of Blatt AJ, Lieberman JM, Hoover DR, Kaufman HW The objective of this study was to estimate the rates of testing, prevalence, and follow-up testing for chlamydial and gonococcal infection in a nationally based population that is comparable with the US pregnant population in terms of age and race. Read the Hologic clinical summary document for Blatt AJ, Lieberman JM, Hoover DR, Kaufman HW. Please visit PubMed for the full text article.

Abstract: Chapin K, Andrea S Read the Hologic abstract document for Chapin K, Andrea S. Please visit PubMed for the full text article.    

For patients with symptoms of preterm labor at weeks 24-34, this example protocol guides a healthcare provider through the critical steps of preterm birth risk assessment, utilizing all available diagnostic tools, and recommends the corresponding patient management therapies/treatment plans.

Clinical Summary of Rose CH, McWeeney DT, Brost BC et al. Am J Obstet Gynecol 2010. The purpose of this study was to determine the effect of a standardized evidence-based protocol for preterm labor evaluation on resource use and obstetrics outcomes. Read the Hologic clinical summary document for Rose CH, McWeeney DT, Brost BC et al. Am J Obstet Gynecol 2010 Please visit PubMed for the full text article.

Clinical Summary of DeFranco EA, Lewis DF, Odibo AO. Am J Obstet Gynecol 2013. The purpose of this study was to systematically review the current medical literature to assess the accuracy of the combination of fetal fibronectin (fFN) plus ultrasound assessment of cervical length (CL) as screening tools for preterm labor and prediction of preterm birth (PTB), and to compare this to the traditional clinical method of digital cervical examination. Read the Hologic clinical summary document for DeFranco EA, Lewis DF, Odibo AO. Am J Obstet Gynecol 2013. Please visit PubMed for the full text article.

Clinical Summary of Walboomers JM et al 1999. Abstract: A recent report that 93 percent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for HPV serum antibodies and HPV DNA. Read the Hologic clinical summary document for: Walboomers JM et al 1999. Please visit PubMed for the full abstract.

Clinical Summary of Khan MJ, Castle PE, Lorincz AT et al From April 1, 1989, to November 2, 1990, a total of 20 810 women in the Kaiser Permanente health plan in Portland, OR, enrolled in a cohort study of HPV and cervical neoplasia. Women were tested for 13 oncogenic HPV types by Hybrid Capture 2 (HC2), and those women with a positive HC2 test were tested for HPV16 and 18. Enrollment Pap smear interpretation and HPV test results were linked to histologically confirmed CIN3 and cervical cancer (> or = CIN3) occurring during 10 years of cytologic follow-up. Cumulative incidence rates were calculated with 95% confidence intervals for each interval up to 122 months using Kaplan-Meier methods. Read the Hologic clinical summary for Khan MJ, Castle PE, Lorincz AT et al. Please visit PubMed for the full text article.